CBD is not converted to THC in rats: A framework interpretation and discussion
VACEK, Jan, Barbora PAPOUSKOVA, Hana HOLCOVÁ POLANSKÁ, Kateřina HÖNIGOVÁ, Jan STORCH, Petr BABULA and Michal MASAŘÍK. CBD is not converted to THC in rats: A framework interpretation and discussion. European Neuropsychopharmacology. Amsterdam: Elsevier, 2021, vol. 50, September 2021, p. 135-136. ISSN 0924-977X. Available from: https://dx.doi.org/10.1016/j.euroneuro.2021.04.003. |
Other formats:
BibTeX
LaTeX
RIS
|
Basic information | |
---|---|
Original name | CBD is not converted to THC in rats: A framework interpretation and discussion |
Authors | VACEK, Jan (203 Czech Republic, guarantor), Barbora PAPOUSKOVA (203 Czech Republic), Hana HOLCOVÁ POLANSKÁ (203 Czech Republic, belonging to the institution), Kateřina HÖNIGOVÁ (203 Czech Republic, belonging to the institution), Jan STORCH (203 Czech Republic), Petr BABULA (203 Czech Republic, belonging to the institution) and Michal MASAŘÍK (203 Czech Republic, belonging to the institution). |
Edition | European Neuropsychopharmacology, Amsterdam, Elsevier, 2021, 0924-977X. |
Other information | |
---|---|
Original language | English |
Type of outcome | Article in a journal |
Field of Study | 30104 Pharmacology and pharmacy |
Country of publisher | Netherlands |
Confidentiality degree | is not subject to a state or trade secret |
WWW | URL |
Impact factor | Impact factor: 5.415 |
RIV identification code | RIV/00216224:14110/21:00123918 |
Organization unit | Faculty of Medicine |
Doi | http://dx.doi.org/10.1016/j.euroneuro.2021.04.003 |
UT WoS | 000688393100016 |
Keywords in English | CBD; THC; rats |
Tags | rivok |
Tags | International impact, Reviewed |
Changed by | Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 2/5/2022 14:19. |
Abstract |
---|
Cannabidiol (CBD) is a non-psychotropic exogenous cannabinoid that is an active component in a number of topical and oral preparations. The pharmacological potential of CBD is determined by its anti-inflammatory and immuno- or neuromodulatory activities. This natural terpenoid is widely used today, and therefore more attention is now paid to examining its safety after the administration of high doses (Epidiolex) and also after low-dose chronic exposure, e.g. in the form of food supplements. CBD is therefore a molecule that has recently gained a great deal of scientific interest, both at the level of basic research and industrial development. |
PrintDisplayed: 7/9/2024 14:19